Abstract
Surveillance test performance and costs are important considerations for a book summarizing the state of the art in patient management after implantation of prosthetic devices for several reasons. First is the growing concern about more efficient use of limited resources, made ever more apparent by the ongoing health care reform debate. Second is the expanding role of “gatekeepers” wielding increasing control over the total cost of health care. Third is the push for clinicians to develop guidelines, driven by the idea that reimbursement could subsequently be tied to adherence to these guidelines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mausner JS, Kramer S. Epidemiology—an introductory text (2nd ed.). Philadelphia, PA: W.B. Saunders, 1985.
Fisher LD, van Belle G. Biostatistics: a methodology for the health sciences. New York: John Wiley, 1993.
Benish WA. Graphic and tabular expressions of Bayes’ theorem. Med Decis Making 1987;7:104–106.
Fagan TJ. Nomogram for Bayes’ formula. N Engl J Med 1975;293:257.
Matchar DB, Simel DL, Geweke JF, Feussner JR. A Bayesian method for evaluating medical test operating characteristics when some patients’ conditions fail to be diagnosed by the reference standard. Med Decis Making 1990;10:102–111.
Irwig L, Glasziou PP, Berry G, Chock C, Mock P, Simpson JM. Efficient study designs to assess the accuracy of screening tests. Am J Epidemiol 1994;140:759–769.
Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: the essentials (2nd ed.). Baltimore, MD: Williams & Wilkins, 1988.
Vecchio TJ. Predictive value of a single diagnostic test in unselected populations. N Engl J Med 1966;274:1171–1173.
Friedman GD. Primer of epidemiology (2nd ed.). New York: McGraw-Hill Book, 1980.
Woolson RF. Statistical methods for the analysis of biomedical data. New York: John Wiley, 1987.
Knottnerus JA, Leffers P. The influence of referral patterns on the characteristics of diagnostic tests. J Clin Epidemiol 1992;45:1143–1154.
Wilson JM, Jungner F. Principles and practice of screening for disease. Geneva: World Health Organization, Public Health Papers; 1968: No. 34.
Feinstein AR. Clinical epidemiology: the architecture of clinical research. Philadelphia, PA: W.B. Saunders, 1985.
Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283–298.
Sox HC, Blatt MA, Higgins HC, Marton KI. Medical decision making. Boston, MA: Butterworths, 1988.
Swets JA. Signal detection and recognition by human observers. New York: John Wiley, 1964.
Centor RM. Signal detectability: the use of ROC curves and their analysis. Med Decis Making 1991;11:102–106.
van der Schouw YT, Straatman H, Verbeek AL. ROC curves and the areas under them for dichotomized tests: empirical findings for logistically and normally distributed diagnostic test results. Med Decis Making 1994;14:374–381.
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29–36.
Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839–843.
Metz CE, Kronman HB. Statistical significance tests for binormal ROC curves. J Math Psych 1980;22:218–243.
Moise A, Clement B, Ducimetiere P, Bourassa MG. Comparison of receiver operating curves derived from the same population: a bootstrapping approach. Comput Biomed Res 1985;18:125–131.
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1985;44:837–845.
McClish DK. Comparing the areas under more than two independent ROC curves. Med Decis Making 1987;7:149–155.
Sox HC, Blatt MA, Higgins MC, Marton KI. Medical decision making. Boston, MA: Butterworths, 1988.
Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttila I, Alhava E. Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50, and CA 242 in pancreatic cancer: results from a prospective study. Br J Cancer 1993;67:852–855.
Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med 1980;302:1109–1117.
Nease RF, Owens DK, Sox HC. Threshold analysis using diagnostic tests with multiple results. Med Decis Making 1989;9:91–103.
Glasziou P. Threshold analysis via the Bayes’ nomogram. Med Decis Making 1991;11:61–62.
Warner KE, Luce BR. Cost-benefit and cost-effectiveness analysis in health care. Ann Arbor, MI: Health Administration Press, 1982.
Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications, 1987.
Weinstein MC. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:716–721.
Dasgupta AK, Pearce DW. Cost-benefit analysis: theory and practice. London: Macmillan, 1972.
Mishan EJ. Cost-benefit analysis. London: George Allen and Unwin, 1975.
Sugden R, Williams AH. The principles of practical cost-benefit analysis. Oxford: Oxford University Press, 1979.
Eastaugh SR. Medical economics and health finance. Dover, MA: Auburn House, 1981.
Robinson R. Cost-utility analysis. BMJ 1993;307:859–862.
Strom BL. Pharmacoepidemiology. New York: Churchill Livingstone, 1989.
Rapoport J, Robertson RL, Stuart B. Understanding health economics. Rockville, MD:, 1982.
Krahn M, Gafni A. Discounting in the economic evaluation of health care interventions. Med Care 1993;31:403–418.
Muller A, Reutzel TJ. Willingness to pay for reduction in fatality risk: an exploratory survey. Am J Public Health 1984;74:808–812.
Zeckhauser R. Procedures for valuing lives. Public Policy 1975;23:419–464.
Jacobs P. The economics of health and medical care. Rockville, MD: Aspen, 1987.
Robinson R. Cost-benefit analysis. BMJ 1993;307(b):924–926.
Mehrez A, Gafni A. Quality adjusted life years and healthy year equivalents. Med Decis Making 1989;9:142–149.
Mehrez A, Gafni A. Healthy-years equivalents versus quality-adjusted life years. Med Decis Making 1993;13:287–292.
Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chron Dis 1978;31:697–704.
Patrick DL, Starks HE, Cain KC, Uhlmann, RF, Pearlman RA. Measuring preferences for health states worse than death. Med Decis Making 1994;14:9–18.
Torrance GW. Social preferences for health states: an empirical evaluation of three measurement techniques. Socio Econ Plan Sci 1976;10:129–136.
von Neumann J, Morgenstern O. Theory of games and economic behavior. New York: John Wiley,1953.
Sonnenberg FA. U-maker 1.0 [computer program]. Microcomputer utility assessment program. New Brunswick, NJ, 1993.
Gafni A. The standard gamble method: what is being measured and how it is interpreted. Health Serv Res 1994;29:207–224.
Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programmes. Health Serv Res 1972;7:118–133.
Weinstein MC. Principles of cost-effective resource allocation in health care organizations. Int J Technol Assess Health Care 1990;6:93–103.
Johannesson M, Pliskin JS, Weinstein MC. A note on QALYs, time trade-off, and discounting. Med Decis Making 1994;14:188–193.
Carr-Hill R. Assumptions of the QALY procedure. Soc Sci Med 1989;29:469–477.
Carr-Hill R. Allocating resources to health care: is the QALY a technical solution to a political problem? Int J Health Serv 1991;21:351–363.
Loomes G, McKenzie L. The use of QALYs in health care decision making. Soc Sci Med 1989;28:299–308.
Wagstaff A. QALYs and the equity-efficiency trade-off. J Health Econ 1991;10:21–41.
Johannesson M, Pliskin JS, Weinstein MC. Are healthy-years equivalents an improvement over quality-adjusted life years. Med Decis Making 1993;13:281–286.
Robinson R. Cost-effectiveness analysis. BMJ 1993;307(c):793–795.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Virgo, K.S. (2006). Assessment of Surveillance Test Performance and Cost. In: Johnson, F.E., Virgo, K.S., Lairmore, T.C., Audisio, R.A. (eds) The Bionic Human. Humana Press. https://doi.org/10.1007/978-1-59259-975-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-975-2_2
Publisher Name: Humana Press
Print ISBN: 978-0-89603-959-9
Online ISBN: 978-1-59259-975-2
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)